ddPCR™ KRAS Screening Multiplex Kit (1863506)
200 x 20 µl reactions, includes 20x assay and ddPCR Supermix for Probes (No dUTP) for screening 7 mutations using the QX200™ or QX200™ AutoDG™ Droplet Digital™ PCR Systems
ddPCR KRAS G12/G13 Screening Kit
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Use the ddPCR KRAS G12/G13 Screening Kit to screen your samples for the following seven KRAS mutations in a single well:
- G12A
- G12C
- G12D
- G12R
- G12S
- G12V
- G13D
Key Features and Benefits
- Superior performance — allows quantification and screening for multiple KRAS mutations in a single well
- High sensitivity — provides sensitive and precise detection down to 0.2% in a single well
- Robust workflow — allows screening of multiple samples in a rapid and cost-effective manner
Kit Components
- Includes 20x ddPCR KRAS G12/G13 Screening Multiplex Assay — 1 x 200 µl and ddPCR Supermix for Probes (No dUTP) — 2 x 1 ml, for screening mutations using the QX200™ or QX200™ AutoDG™ Droplet Digital™ PCR Systems
For extended product descriptions and detail specification information, please visit Bio-Rad.com.
Expanded Droplet Digital PCR Multiplexing Capability Using Two Different Strategies
This application note describes strategies for amplitude-based and probe-mixing multiplexing using the large portfolio of Droplet Digital PCR (ddPCR) Assays available through Bio-Rad.
New Assays for Mutation Detection using Droplet Digital PCR
Carolyn Reifsnyder, Senior Marketing Manager, Bio-Rad Laboratories, Inc., introduces new assays for genome edit detection using the droplet digital PCR system as well as the new ddSEQ™ Single-Cell Isolator, at AACR 2017. She discusses how Bio-Rad’s droplet digital PCR has become a mainstay in the field of liquid biopsy and mutation detection due to the level of sensitivity and precision it can achieve.
Understanding Resistance to Chemotherapy using Liquid Biopsies and Droplet Digital PCR
In this interview filmed at AACR 2017, hear how researchers at the Dana-Farber Cancer Institute are using Droplet Digital PCR to detect key mutations in cell-free DNA from liquid biopsies, helping improve understanding of drug resistance development as well as inform treatment decisions.
Risk Factors for Prostate Cancer Identified and Validated Using Droplet Digital PCR
Learn how digital PCR is advancing cancer genetics research at Louisiana State University Health Sciences Center
Molecular Diagnostics News Update
The very latest molecular diagnostic news, interviews and videos
Presentations at the AACR Annual Meeting to Highlight Advances in Cancer Research Made Possible by Bio-Rad’s Droplet Digital™ PCR Technology
Tailoring Treatments and Tracking Mutations with Liquid Biopsies possible with ddPCR™ technology
